Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices 28663 

may also be obtained by accessing its 

website (http://www.usitc.gov). Persons 

with mobility impairments who will 

need special assistance in gaining access 

to the Commission should contact the 

Office of the Secretary at 202–205–2000. 

Background: All dates and other 

information relating to this investigation 

remain the same as in the Commission’s 

notice of investigation and public 

hearing issued on May 23, 2018 and 

published in the Federal Register of 

May 25, 2018 (83 FR 24342). 

By order of the Commission. 

Issued: June 14, 2018. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2018–13176 Filed 6–19–18; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Fisher Clinical Services, 

Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before July 20, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 20, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on March 

16, 2018, Fisher Clinical Services, Inc., 

7554 Schantz Road, Allentown, 

Pennsylvania 18106 applied to be 

registered as an importer of 1-[1-(2- 

Thienyl)cyclohexyl]pyrrolidine (7473), 

a basic class of controlled substance 

listed in schedule I. 

The company plans to import the 

controlled substance in finished dosage 

form for testing and clinical trials 

purposes only. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under to 21 U.S.C. 

952(a)(2). Authorization will not extend 

to the import of FDA approved or nonapproved finished dosage forms for 

commercial sale. 

Dated: June 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–13224 Filed 6–19–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Registration 

ACTION: Notice of registration. 

SUMMARY: Registrants listed below have 

applied for and been granted 

registration by the Drug Enforcement 

Administration (DEA) as bulk 

manufacturers of various classes of 

schedule I and II controlled substances. 

SUPPLEMENTARY INFORMATION: The 

companies listed below applied to be 

registered as bulk manufacturers of 

various basic classes of controlled 

substances. Information on previously 

published notices is listed in the table 

below. No comments or objections were 

submitted for these notices. 

Company FR Docket Published 

AMRI Rensselaer, Inc .................................................................................................................................... 83 FR 5808 February 9, 2018. 

Stepan Company ........................................................................................................................................... 83 FR 9029 March 2, 2018. 

Research Triangle Institute ............................................................................................................................ 83 FR 10523 March 9, 2018. 

Rhodes Technologies .................................................................................................................................... 83 FR 12407 March 21, 2018. 

Synthcon, LLC ............................................................................................................................................... 83 FR 13141 March 27, 2018. 

National Center for Natural Products—Research NIDA MPROJECT .......................................................... 83 FR 13522 March 29, 2018. 

Insys Manufacturing LLC ............................................................................................................................... 83 FR 13522 March 29, 2018. 

Navinta LLC ................................................................................................................................................... 83 FR 13521 March 29, 2018. 

The DEA has considered the factors in 

21 U.S.C. 823(a) and determined that 

the registration of these registrants to 

manufacture the applicable basic classes 

of controlled substances is consistent 

with the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971. The DEA 

investigated each of the company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing each company’s physical 

security systems, verifying each 

company’s compliance with state and 

local laws, and reviewing each 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the DEA has granted a 

registration as a bulk manufacturer to 

the above listed companies. 

Dated: June 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–13223 Filed 6–19–18; 8:45 am] 

BILLING CODE 4410–09–P 


sradovich on DSK3GMQ082PROD with NOTICES